Swetha RaniKanduri United StatesOchsner Health, New Orleans, LA

I am Swetha Kanduri, completed medical school from Osmania medical college in India, residency from University of Alabama and Fellowship from University of Mississippi Medical Center. Currently working as Assistant Professor at Ochsner Health and serves as Associate Fellowship Program Director for the Nephrology Fellowship Program. Research Interest in Hepatorenal syndrome and Onco-Nephrology with particular focus on electrolyte abnormalities in cancer patients, GLP-1RA in cancer patients ________________________________________

Upload Picture

https://storage.unitedwebnetwork.com/files/1099/d195a7b7d7c5a9ccca222bf401e21952.jpeg

First name

Swetha Rani

Last name

Kanduri

Institution

Country

United States

Saturday, February 8, 2025

Time	Session

14:15 15:45	Looking into the Crystal Ball – Where Will We Be 5 Years from Now? SK2002 RajkumarSharma Chair rksnepho206@gmail.comIndiaDirector and Head of Department of Nephrology, Medanta Hospital, Lucknow Swetha RaniKanduri Chair svetarani@gmail.comUnited StatesOchsner Health, New Orleans, LA Evaluating Kidney Allograft Dysfunction SK2002-001 SumitMohan Speaker mohan.sumit@gmail.comUnited StatesColumbia University Advances in Glomerular Disease Treatment SK2002-02 Jonathan Barratt Speaker jb81@leicester.ac.ukUnited KingdomUniversity of Leicester, Leicester, UK Risk Prediction in AKI and CKD SK2002-03 NavdeepTangri Speaker ntangri@yahoo.comCanadaUniversity of Manitoba, SOGH Chronic Disease Innovation Centre Prioritizing Patient-friendly Dialysis SK2002-04 EdwinaBrown Speaker United KingdomImperial College Healthcare NHS Trust Glomerular Disease Diagnostics SK2002-01 SanjeevSethi Speaker sethi.sanjeev@mayo.eduUnited StatesMayo Clinic Q&A SK2002-06 Brahmkamal Hall - Plenary Hall

Time

Session

14:15

15:45

Looking into the Crystal Ball – Where Will We Be 5 Years from Now?

SK2002

RajkumarSharma Chair rksnepho206@gmail.comIndiaDirector and Head of Department of Nephrology, Medanta Hospital, Lucknow

Swetha RaniKanduri Chair svetarani@gmail.comUnited StatesOchsner Health, New Orleans, LA

Evaluating Kidney Allograft Dysfunction

SK2002-001

SumitMohan Speaker mohan.sumit@gmail.comUnited StatesColumbia University
Advances in Glomerular Disease Treatment

SK2002-02

Jonathan Barratt Speaker jb81@leicester.ac.ukUnited KingdomUniversity of Leicester, Leicester, UK
Risk Prediction in AKI and CKD

SK2002-03

NavdeepTangri Speaker ntangri@yahoo.comCanadaUniversity of Manitoba, SOGH Chronic Disease Innovation Centre
Prioritizing Patient-friendly Dialysis

SK2002-04

EdwinaBrown Speaker United KingdomImperial College Healthcare NHS Trust
Glomerular Disease Diagnostics

SK2002-01

SanjeevSethi Speaker sethi.sanjeev@mayo.eduUnited StatesMayo Clinic
Q&A

SK2002-06

Brahmkamal Hall - Plenary Hall

Sunday, February 9, 2025

Time	Session

09:00 10:30	Metabolic Crossroads: Kidneys, Liver Disease, and the Gut IK06 GloriaAshuntantang Chair CameroonUniversity of Bamenda, Cameroon Narayan Prasad Chair IndiaSanjay gandhi Postgraduate Institute of Medical Sciences, Lucknow, India Dr Sree BhushanRaju Chair sreebhushan@hotmail.comIndia Hepatorenal Syndrome and New Treatments for AKI in Cirrhosis IK06-01 Swetha RaniKanduri Speaker svetarani@gmail.comUnited StatesOchsner Health, New Orleans, LA Do Gut Microbiota Contribute to Kidney Disease? If so, What Can We Do About it? IK06-02 GrietGlorieux Speaker GRIET.GLORIEUX@UGent.beBelgiumUGent What Should Nephrologists Know About Metabolic Dysfunction-associated Fatty Liver Disease IK06-03 Angela Yee-MoonWang Speaker SingaporeHong Kong/Singapore Measuring Kidney Function in Liver Disease - Pitfalls and Solutions IK06-04 SmitaDivyaveer Speaker divyaveer.ss@gmail.comIndiaPOST GRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH, CHANDIGARH, INDIA Q&A IK06-05 Amaltas Hall B101-A

Time

Session

09:00

10:30

Metabolic Crossroads: Kidneys, Liver Disease, and the Gut

IK06

GloriaAshuntantang Chair CameroonUniversity of Bamenda, Cameroon

Narayan Prasad Chair IndiaSanjay gandhi Postgraduate Institute of Medical Sciences, Lucknow, India

Dr Sree BhushanRaju Chair sreebhushan@hotmail.comIndia

Hepatorenal Syndrome and New Treatments for AKI in Cirrhosis

IK06-01

Swetha RaniKanduri Speaker svetarani@gmail.comUnited StatesOchsner Health, New Orleans, LA
Do Gut Microbiota Contribute to Kidney Disease? If so, What Can We Do About it?

IK06-02

GrietGlorieux Speaker GRIET.GLORIEUX@UGent.beBelgiumUGent
What Should Nephrologists Know About Metabolic Dysfunction-associated Fatty Liver Disease

IK06-03

Angela Yee-MoonWang Speaker SingaporeHong Kong/Singapore
Measuring Kidney Function in Liver Disease - Pitfalls and Solutions

IK06-04

SmitaDivyaveer Speaker divyaveer.ss@gmail.comIndiaPOST GRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH, CHANDIGARH, INDIA
Q&A

IK06-05

Amaltas Hall B101-A